Literature DB >> 18369815

RNA interference using a plasmid construct expressing short-hairpin RNA.

Serene R Lai1, Lucy G Andrews, Trygve O Tollefsbol.   

Abstract

RNA interference (RNAi) is one of the most commonly used procedures for gene targeting in today's cutting edge technology and has great potential for use in clinical therapy. Using a plasmid construct that exogenously expresses short-hairpin RNAs (shRNAs) targeting a desired gene transcript not only helps to study the downstream effects of a gene product but also offers an alternative to viral vectors for gene therapy. Using a plasmid vector to knockdown a gene allows for long-term and permanent gene knockdown, without the need to generate knockout genotypes. Here, we detail the methodology for constructing a plasmid targeting the human telomerase reverse transcriptase (hTERT) gene through RNAi using the Ambion pSilencer system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18369815      PMCID: PMC2423213          DOI: 10.1007/978-1-60327-070-0_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Many commonly used siRNAs risk off-target activity.

Authors:  Ola Snøve; Torgeir Holen
Journal:  Biochem Biophys Res Commun       Date:  2004-06-18       Impact factor: 3.575

2.  Local RNA target structure influences siRNA efficacy: a systematic global analysis.

Authors:  Marita Overhoff; Martina Alken; Rosel Kretschmer-Kazemi Far; Marc Lemaitre; Bernard Lebleu; Georg Sczakiel; Ian Robbins
Journal:  J Mol Biol       Date:  2005-05-13       Impact factor: 5.469

Review 3.  Gene therapy progress and prospects: recent progress in transgene and RNAi expression cassettes.

Authors:  C R Ill; H C Chiou
Journal:  Gene Ther       Date:  2005-05       Impact factor: 5.250

4.  A system for stable expression of short interfering RNAs in mammalian cells.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Science       Date:  2002-03-21       Impact factor: 47.728

5.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

  5 in total
  5 in total

Review 1.  Strategies targeting telomerase inhibition.

Authors:  Huaping Chen; Yuanyuan Li; Trygve O Tollefsbol
Journal:  Mol Biotechnol       Date:  2008-10-28       Impact factor: 2.695

2.  The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion.

Authors:  Mamadou Keita; Magdalena Bachvarova; Chantale Morin; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Alexandra Sebastianelli; Xuan Bich Trinh; Dimcho Bachvarov
Journal:  Cell Cycle       Date:  2013-02-26       Impact factor: 4.534

Review 3.  Therapeutic Targets in Telomerase and Telomere Biology of Cancers.

Authors:  Rajendra Prasad; Deeksha Pal; Wajid Mohammad
Journal:  Indian J Clin Biochem       Date:  2020-03-10

Review 4.  Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression.

Authors:  Song He; Dechun Zhang; Fang Cheng; Fanghong Gong; Yanan Guo
Journal:  Mol Biol Rep       Date:  2009-01-01       Impact factor: 2.316

5.  VEGF siRNA delivered by polycation liposome-encapsulated calcium phosphate nanoparticles for tumor angiogenesis inhibition in breast cancer.

Authors:  Jinliang Chen; Xiaoyi Sun; Rong Shao; Yichao Xu; Jianqing Gao; Wenquan Liang
Journal:  Int J Nanomedicine       Date:  2017-08-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.